MCK · News · 20260805N

Specialty Drug Demand Growth

MCKESSON CORP · 2026-08-05 · Importance 20 · Surprise 24

Demand for specialty medicines remained strong, with increased prescription volumes supporting McKesson’s oncology and specialty drug businesses. North American Pharmaceutical and Oncology were identified as key growth areas, alongside biopharma services. The trend reflects continued healthcare-provider and patient demand for high-cost specialty therapies, although pricing dynamics may moderate distribution revenue growth.

Key facts

• McKesson's specialty drug business and oncology were cited as drivers of strong growth and the raised forecast. source
• Increased prescription volumes and high demand for specialty medicines were cited as bolstering Q1 performance. source